Developmental Immunotoxicity in Rodents

Immunotoxicology Strategies for Pharmaceutical Safety Assessment

Volumn , Issue , 2008, Pages 271-297

  Dietert, Rodney R ^a   Burns Naas, Leigh Ann ^b  

^a Department of Obstetrics Gynecology   (United States)

^b PFIZER INC   (United States)

Author keywords

Developmental immunotoxicology (DIT) assessment methods; Evaluating developmental pharmaceutical immunotoxicity; Rodent developmental immunotoxicity testing

Indexed keywords

EID: 84889291972     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470386385.ch21     Document Type: Chapter

References (76)

1. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002;110:315-322.
2. Blyler G, Landreth KS, Barnett J. Gender-specific effects of prenatal chlordane on myeloid cell development. Fundam Appl Toxicol 1994;23:188-193.
3. Bunn TL, Parsons PJ, Kao E, Dietert RR. Exposure to lead during critical windows of embryonic development: differential immunotoxic outcome based on stage of exposure and gender. Toxicol Sci 2001a;64:57-66.
4. Bunn T, Ladics GS, Holsapple MP, Dietert RR. Developmental immunotoxicology assessment in the rat: age, gender and strain comparisons after exposure to Pb. Toxicol Methods 2001b;11:41-58.
5. Bunn TL, Parsons PJ, Kao E, Dietert RR. Gender-based profiles of developmental immunotoxicity to lead in the rat: assessment in juveniles and adults. J Toxicol Environ Health Part A 2001c;64:101-118.
6. Burgi B, Lichtensteiger W, Schlumpf M. Diazepam-binding inhibitory/acyl-Co-A-binding protein mRNA and peripheral benzodiazepine receptor mRNA in endocrine and immune tissues after prenatal diazepam exposure of male and female rats. J Endocrinol 2000;166:163-171.
7. Burns-Naas LA, Dearman RJ, Germolec DR, Kaminski NE, Kimber I, Ladics GS, Luebke RW, Pfau JC, Pruett SB. " Omics " technologies and the immune system. Toxicol Mech Methods 2006;16:101-119.
8. Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP. Invited Review-What's so special about the developing immune system? Int J Toxicol 2008;27(2):223-254.
9. Carney EW, Zablotny CL, Marty MS, Crissman JW, Anderson PA, Woolhiser M, Holsapple M. The effects of feed restriction during in utero and postnatal development in rats. Toxicol Sci 2004;82:237-249.
10. Chapin RE, Harris MW, David BJ, Ward SM, Wilson RE, Mauney MA, Lockhart AC, Smialowicz RJ, Moser VC, Burka LT, Collins BJ. The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune, and reproductive system function. Fundam Appl Toxicol 1997;40:138-157.
11. Dietert RR, Dietert JM. Early-life immune insult and developmental immunotoxicity (DIT)-associated diseases: potential of herbal-and fungal-derived medicinals. Curr Med Chem 2007;14:1075-1085.
12. Dietert RR, Holsapple MP. Methodologies for developmental immunotoxicity (DIT) testing. Methods 2007;41:23-131.
13. Dietert RR, Piepenbrink MS. Perinatal immunotoxicity: why adult exposure assessment fails to predict risk. Environ Health Perspect 2006a;114:477-483.
14. Dietert RR, Piepenbrink MS. Lead and immune function. Crit Rev Toxicol 2006b;36:358-385.
15. Dietert RR, Etzel RA, Chen D, Halonen M, Holladay SD, Jarabek AM, Landreth K, Peden D, Pinkerton K, Smialowicz RJ, Zoetis T. Windows of vulnerability for the immune and respiratory systems. Environ Health Perspect 2000;108:483-490.
16. Dietert RR, Lee J-E, Olsen J, Fitch K, Marsh JA. Developmental immunotoxicity of dexamethasone: comparison of fetal versus adult exposures. Toxicology 2003;196:163-176.
17. Drela N, Zesko I. Gender-related early immune changes in mice exposed to airborne suspended matter. Immunopharmacol Immunotoxicol 2003;25:101-121.
18. Dunn T. Normal and pathologic anatomy of the reticular tissue in laboratory mice. J Natl Cancer Inst 1954;14:1281-1433.
19. EMEA (European Medicines Agency, Committee for Human Medicinal Products). Guideline on the need for non-clinical testing in juvenile animals on human pharmaceuticals for paediatric indications (Draft). 2005. EMEA/CHMP/SWP/169215/2005.
20. Faith RE, Luster MI, Kimmel CA. Effect of chronic developmental lead exposure on cell-mediated immune functions. Clin Exp Immunol 1979;35:413-420.
21. FDA (United States Food and Drug Administration). Guidance for Industry-Immunotoxicology evaluation of investigational new drugs. Office of Training and Communication, Division of Drug Information, Center for Drug Evaluation and Research, U.S. Department of Health and Human Services. 2002.
22. FDA (United States Food and Drug Administration). Guidance for Industry-Nonclinical safety evaluation of pediatric drug products. Office of Training and Communication, Division of Drug Information, Center for Drug Evaluation and Research, U.S. Department of Health and Human Services. 2006.
23. Fenaux JB, Gogal RM Jr, Ahmed SA. Diethylstilbesterol exposure during fetal development affects thymus: studies in fourteen-month-old mice. J Reprod Immunol 2004;64:75-90.
24. Gehrs BC, Smialowicz RJ. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 1999;134:70-88.
25. Guo TL, White KL Jr, Brown RD, Declos KB, Newbold RR, Weis C, Germolec DR, McCay JA. Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. Toxicol Appl Pharmacol 2002;181:219-227.
26. Haley PJ. Species differences in the structure and function of the immune system. Toxicology 2003;188(1):49-71.
27. Haley P, Perry R, Ennulat D, Frame S, Johnson C, Lapointe JM, Nyska A, Snyder P, Walker D, Walter G. STP position paper: best practice guideline for the routine pathology evaluation of the immune system. Toxicol Pathol 2005;33:404-408.
28. Holladay SD, editor. Developmental Immunotoxicology. Boca Raton, FL : CRC Press, 2005.
29. Holladay, SD, Smialowicz RJ. Development of the murine and human immune system:differential effects of immunotoxicants depend on time of exposure. Environ Health Perspect 2000;108:463-473.
30. Holladay SD, Blaylock BL, Comment CE, Heindel JJ, Fox WM, Korach KS, Luster MI. Selective prothymocyte targeting by prenatal diethylstilbesterol exposure. Cell Immunol 1993;152:131-142.
31. Holsapple MP. Developmental immunotoxicology and risk assessment: a workshop summary. Human Exp Toxicol 2002;21:473-478.
32. Holsapple MP, West LJ, Landreth KS. Species comparison of anatomical and functional immune system development. Birth Defects Res Part B 2003;68:321-334.
33. Holsapple MP, Burns-Naas LA, Hastings KL, Ladics GS, Lavin GS, Makris SL, Yang Y, Luster MI. A proposed testing framework for developmental immunotoxicology (DIT). Toxicol Sci 2005;83:18-24.
34. Holsapple MP, van der Laan JW, Van Loveren H. Developmental of a framework for developmental immunotoxicity (DIT) testing. In: Immunotoxicology and Immunopharmacology , 3rd eds., edited by Luebke R, House R, Kimber I, pp. 347-361. Boca Raton, FL : CRC Press, 2007.
35. Hussain I, Piepenbrink M, Fitch KJ, Marsh JA, Dietert RR. Developmental immunotoxicity of cyclosporin-A in rats: age-associated differential effects. Toxicology 2005;206:273-284.
36. International Conference on Harmonization (ICH). Guidance for Industry. S5A Detection of Toxicity to Reproduction for Medicinal Products. 1994.
37. International Conference on Harmonization (ICH). Guidance for Industry. S8 Immunotoxicity Studies for Human Pharmaceuticals. 2006.
38. Karrow NA, Guo TL, Declos KB, Newbold RR, Weis C, Germolec DR, White KL Jr, McCay JA. Nonylphenol alters the activity of splenic NK cells and the number of leukocyte subpopulations in Sprague-Dawley rats: a two generation feeding study. Toxicology 2004;196:237-245.
39. Kimura S, Eldridge JH, Michalek SM, Morisaki I, Hamada S, McGhee JR. Immunoregulation in the rat: ontogeny of B cell responses to types 1, 2, and T-dependent antigens. J Immunol 1985;134:2839-2852.
40. Ladics GS, Smith C, Bunn TL, Dietert RR, Anderson PK, Wiescinski CM, Holsapple MP. Characterization of an approach to developmental immunotoxicology assessment in the rat using SRBC as the antigen. Toxicol Methods 2000;10:283-311.
41. Ladics GS, Chapin RE, Hastings KL, Holsapple MP, Makris SL, Sheets LP, Woolhiser MR, Burns-Naas LA. Developmental toxicology evaluations-issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. Toxicol Sci 2005;88:24-29.
42. Landreth KS. Critical windows in development of the rodent immune system. Hum Exp Toxicol 2002;21:493-498.
43. Landreth KS, Dodson SVM. Development of the rodent immune system. In: Developmental Immunotoxicology, edited by Hollday SD, pp. 3-19. Boca Raton, FL : CRC Press, 2005.
44. Lee JE, Naqi SA, Kao E, Dietert RR. Embryonic exposure to lead: comparison of immune and cellular responses in unchallenged and virally stressed chickens. Arch Toxicol 2002;75:717-724.
45. Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cook ID. The role of T helper cytokines in human reproduction. Fertil Steril 2000;73:136-142.
46. Luebke R, Chen D, Dietert RR, King M, Yang Y, Luster MI. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B 2006;9(1):1-26.
47. Luster MI, Faith RE, McLachlan JA. Modulation of the antibody response following in utero exposure to diethylstilbestrol. Bull Environ Contam Toxicol 1978;20:433-437.
48. Luster MI, Faith RE, Mclauchlan JA, Clark GC. Effect of in utero exposure to diethylstilbesterol on the immune response in mice. Toxicol Appl Pharmacol 1979;47:279-285.
49. Luster MI, Portier C, Pait DG, White KL Jr, Gennings C, Munson AE, Rosenthal GJ. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 1992;18:200-210.
50. Luster MI, Dean JH, Germolec DR. Consensus workshop on methods to evaluate developmental immunotoxicity. Environ Health Perspect 2003;111:579-583.
51. Luster MI, Johnson VJ, Yucesoy B, Simeonova P. Biomarkers to assess potential developmental immunotoxicity in children. Toxicol Appl Pharmacol 2005;206:229-236.
52. Miller TE, Golemboski KA, Ha RS, Bunn T, Sanders FS, Dietert RR. Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats. Toxicol Sci 1998;42:129-135.
53. Ng SP, Silverstone AE, Zai ZW, Zelifoff JT. Effects of prenatal exposure to cigarette smoke on offspring tumor susceptibility and immune mechanisms. Toxicol Sci 2006;89:135-144.
54. Peden-Adams MM, Eudaly JG, Heesmann LM, Smythe J, Miller J, Gilkeson GS, Keil DE. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. J Environ Sci Health A 2006;41:249-271.
55. Pillet S, Rooney AA, Bouguegneau JM, Cyr DG, Fournier M. Sex-specific effects of neonatal exposure to low levels of cadmium through mother's milk on development and immune functions of juvenile and adult rats. Toxicology 2005;209:289-301.
56. Redei E, Halasz I, Li LF, Prystowsky MB, Aird F. Maternal adrenalectomy alters immune and endocrine functions of fetal alcohol-exposed male offspring. Endocrinology 1993;133:452-460.
57. Rooney AA, Maltuka RA, Luebke RW. Developmental atrazine exposure suppresses immune function in male, but not female Sprague-Dawley rats. Toxicol Sci 2003;76:366-375.
58. Rowe AM, Brundage KM, Schafer R, Barnett JB. Immunomodulatory effects of maternal atrazine exposure on male Balb/c mice. Toxicol Appl Pharmacol 2006;214:69-77.
59. Scharer K. The effect of chronic underfeeding on organ weights of rats. How to interpret organ weight changes in cases of marked growth retardation in toxicity tests? Toxicology 1977;7(1):45-56.
60. Schlumpf M, Ramseier H, Lichtensteiger W. P renatal diazepam induced persisting depression of cellular immune responses. Life Sci 1989;44:493-501.
61. Schlumpf M, Lichtensteiger W, van Louveren H. Impaired host resistance to Trichinella spiralis as a consequence of prenatal treatment of rats with diazepam. Toxicology 1994;94:223-230.
62. Schwartz E, Tornaben JA, Boxill GC. The effects of food restriction on hematology, clinical chemistry and pathology in the albino rat. Toxicol Appl Pharmacol 1973;25(4):515-524.
63. Selgrade MK, Lemansky RF Jr, Gilmour MI, Neas LM, Ward MD, Henneberger PK, Weissman DN, Hoppin JA, Dietert RR, Sly PD, Geller AM, Enright PL, Backus GS, Bromberg PA, Germolec DR, Yeatts KB. Induction of asthma and the environment:what we know and need to know. Environ Health Perspect 2006;114:615-619.
64. Silva IA, El Nabawi M, Hoover D, Silbergeld EK. Prenatal HgCl2 exposure in BALB/cmice: gender-specific effects on the ontogeny of the immune system. Dev Comp Immunol 2005;29:171-183.
65. Smialowicz RJ. The rat as a model in developmental immunotoxicology. Hum Exp Toxicol 2002;21:513-519.
66. Smialowicz RJ, Brundage KM, Barnett JB. Immune system ontogeny and developmental immunotoxicology. In: Immunotoxicology and Immunopharmacology, 3rd eds., edited by Luebke R, House R, Kimber I, pp. 327-345. Boca Raton, FL : CRC Press, 2007.
67. Smyth RL. Asthma: a major pediatric health issue. Respir Res 2002 ; 3 (1): S3-S7.
68. Stahlmann R, Korte M, Van Loveren H, Vos JG, Theil R, Neubert D. Abnormal thymus development and impaired function of the immune system in rats after prenatal exposure to aciclovir. Arch Toxicol 1992;66:551-559.
69. Thurston GD, Lippmann M, Scott MB, Fine JM. Summer time haze air pollution and children with asthma. Am J Respir Crit Care Med 1997;155:654-660.
70. Timonen KL, Pekkanen J. Air pollution and respiratory health among children with asthmatic or cough symptoms. Am J Resp Crit Care Med 1997;156:546-552.
71. Voderstrasse BA, Cundiff JA, Lawrence BP. A dose-response study of the effects of prenatal and lactational exposure to TCDD on the immune response to Influenza A virus. J Toxicol Environ Health Part A 2006;69:445-463.
72. von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohn O, Von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000;30:187-193.
73. Vos JG, Moore JA. Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int Arch Allergy 1974 ; 47 :777-794.
74. Weisglas-Kuperus N, Sas TC, Koopman-Esseboom C, van der Zwan CW, De Ridder MA, Beishuizen A, Hooijkaas H, Sauer PJ. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediatr Res 1995;28:404-410.
75. White KL Jr, Germolec DR, Booker CD, Hernendez DM, Mccay JA, Declos KB, Newbold RR, Weis C, Guo TL. Dietary methoxychlor exposure modulates splenic natural killer cell activity, antibody-forming cell response and phenotypic marker expression in F0 and F1 generations of Sprague Dawley rats. Toxicology 2005;207:271-281.
76. Yeatts KB, Sly P, Shore S, Weiss S, Martinez F, Geller A, Bromberg P, Enright P, Koren H, Weissman D, Selgrade M. A brief targeted review of susceptibility factors, environmental exposures, asthma incidence, and recommendations for future asthma incidence research. Environ Health Perspect 2006;114:634-640.